Фуцидин Г

Quick links

Choose a section

Quick links to important sections

Advertisements

Фуцидин Г

Selected form

Advertisements
Advertisements

Overview of Фуцидин Г

Quick Facts

Property Description
Active ingredients Fusidic Acid and Hydrocortisone
Form Cream or Ointment
Pharmacological class Topical Anti-infective and Corticosteroid Combination
Common use Treating infected or inflamed skin conditions
Origin Semi-synthetic (derived from natural sources)

What Type of Medicine is Фуцидин Г?

Фуцидин Г is a prescription-only dermatological combination medicine that is applied topically to the skin, providing a fixed-dose dual treatment for skin conditions with both bacterial infection and inflammation. Its pharmacological classification is a Topical Anti-infective and Corticosteroid Combination. This formulation is clinically recognized for its targeted efficacy in situations where an inflammatory skin issue is complicated by a bacterial presence.

What Are the Active Ingredients in Фуцидин Г?

The medicine is defined by its two primary active ingredients: the antibiotic Fusidic Acid and the mild corticosteroid Hydrocortisone. The antibiotic component works by preventing specific bacteria from growing. The corticosteroid, Hydrocortisone, acts as an anti-inflammatory agent, which is frequently utilized to reduce the redness, swelling, and itching associated with skin conditions.

What Form Does Фуцидин Г Come In?

Фуцидин Г is typically supplied as a cream or an ointment, both of which are strictly intended for topical application. The cream is a lighter preparation, while the ointment is oilier and may be better suited for drier, scaly skin. This localized method of application ensures that the medicine is concentrated at the site where it is needed most, which is a key differentiating feature from systemic (oral) medications.

Advertisements

What side effects are possible with Фуцидин Г?

Possible Side Effects and Safety Information

The official safety documentation for the Fusidic Acid/Hydrocortisone combination classifies potential adverse reactions predominantly as local skin effects and effects related to the corticosteroid component. The frequencies of reactions are categorized according to regulatory standards.

Frequency Classification Examples of Officially Listed Adverse Reactions
Uncommon (1/1,000 to < 1/100) Skin irritation, burning sensation, pruritus (itching), rash, contact dermatitis.
Rare (1/10,000 to < 1/1,000) Hypersensitivity (allergic reaction), angioedema.

The most frequently reported effects are minor application site reactions that include burning and irritation. Adverse effects are grouped into System-Organ Classes such as Skin and subcutaneous tissue disorders and Immune system disorders.

Serious Adverse Reactions and Systemic Risk

The potential for rare, serious side effects, such as severe Hypersensitivity reactions, is documented. Due to the hydrocortisone content, there is a theoretical risk of systemic effects, including Adrenal Suppression or Cushing's Syndrome. These are rare class effects primarily linked to prolonged topical administration, application to large surface areas, or use under occlusive dressings.

Safety Restrictions and Special Populations

Official regulatory documents state that the product is contraindicated in the presence of certain untreated skin infections (e.g., viral or fungal infections), rosacea, and perioral dermatitis. Additionally, children and infants are noted to be more susceptible to systemic toxicity from the corticosteroid component due to their higher skin surface area to body mass ratio, requiring specific caution regarding the duration of use.

Advertisements

Overdose and Emergency Response

Overdose and when to seek help

Official Manifestations of Overdose

Overdose from topical use is highly unlikely when the medicine is applied as directed. However, regulatory information notes that prolonged or excessive application can lead to the systemic absorption of the Hydrocortisone component, resulting in recognized clinical manifestations. These manifestations may include signs of Hypercortisolism (Cushingoid features) and suppression of the HPA axis, clinically known as Adrenocortical Insufficiency. Severe adrenal suppression is classified by regulatory authorities as a serious, life-threatening condition that demands urgent treatment. Symptoms linked to severe suppression may include low blood pressure, dizziness, and fainting.

Required Emergency Actions

Official guidance mandates seeking immediate medical attention if the cream or ointment is accidentally swallowed. Following accidental oral intake, individuals are advised to contact a poison control center right away, even in the absence of immediate symptoms. Regulatory documents state that management for confirmed overdose effects is generally symptomatic and supportive, as no specific antidote is known for this combination medicine.

Population-Specific and Component Notes

Children are documented to be more sensitive to the systemic effects of the corticosteroid component. Overexposure in pediatric cases may be associated with manifestations such as delayed weight gain or growth retardation. Regulatory documentation notes that no information is available concerning potential symptoms and signs due to overdose administration of topically applied Fusidic Acid alone.

Advertisements

Therapeutic Uses of Фуцидин Г

What Фуцидин Г Treats: Main Uses and Benefits

The primary therapeutic use of this combination medicine is to address infected inflammatory dermatoses, which are skin conditions where inflammation is concurrent with a secondary bacterial infection. This makes it relevant for conditions like eczema and various forms of dermatitis (such as contact dermatitis) when they have become complicated by bacterial growth. This dual-action approach is specifically indicated for cases of eczema and dermatitis where a secondary bacterial infection is present.

The medicine is commonly used in acute episodes to help manage challenging symptoms of discomfort, including pronounced pruritus (itching), severe redness (erythema), and localized swelling (edema). The combination of active ingredients contributes to easing the overall symptom burden during periods of heightened symptoms.

“This medicine is applied across domains where additional symptomatic support is needed to concurrently manage the skin's inflammatory response and bacterial presence.”

This supportive relief is valuable in clinical scenarios marked by the sudden escalation of symptoms in chronic issues or in lesions such as infected insect bites. Its use offers short-term symptomatic assistance to stabilize the condition and supports the process of resolution of the lesions.


Quick Fact: Relief for Dual Discomfort Symptom Type Therapeutic Focus
Inflammatory Symptoms Reducing redness and swelling
Infection Symptoms Addressing bacterial presence and associated crusting
Patient Benefit Contributing to improved day-to-day comfort
Advertisements

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Фуцидин Г — Official Regulatory Information

The eligibility profile for Фуцидин Г (Fusidic Acid and Hydrocortisone) is strictly defined by regulatory authorities, with use permitted in adults and conditionally in children and pregnant or breastfeeding women.


Eligibility Scope

Classification Population/Condition
Populations Permitted Adults, Pregnant Women (if clinically needed), and Breastfeeding Women (avoiding application on the breast).
Age-Related Rules Permitted in Children and Infants, but long-term continuous topical therapy must be avoided.
Absolute Contraindications Hypersensitivity to any component, or primary skin infections caused by viruses (e.g., Herpes simplex), fungi, or Tuberculosis.
Conditions Forbidding Use Rosacea, Perioral Dermatitis, and rashes following Vaccinations.

Eligibility-Related Restrictions

Use is not recommended for conditions like Acne Vulgaris, Atrophic Skin, Cutaneous Ulcers, or Perianal/Genital Pruritus. Application must be avoided near the eyes, on open wounds, or on mucous membranes.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents for the topical combination product Фуцидин Г (Fusidic Acid / Hydrocortisone Acetate) generally state that formal drug interaction studies have not been conducted with other medicines.

Documented Interaction Status

The interaction profile of this topical medicine is defined by the absence of specific interaction data, which is common for products with limited systemic absorption. The official prescribing information from various national health agencies reflects this constraint.

Interaction Category Regulatory Statement (Summary)
Drug-Drug Interactions Formal interaction studies have not been performed.
Drug-Product Interactions No specific interactions with food, alcohol, or herbal products are documented in official interaction sections.

Clinical Constraints

The lack of documented interaction data imposes a practical constraint on prescribing. Healthcare providers are generally advised by regulatory authorities to be informed of all other topical and systemic medicines a patient is using. While the risk of clinically significant systemic drug-drug interactions is considered low due to the topical route of administration and limited systemic absorption, this information ensures comprehensive patient care and cautious co-administration.

Therefore, the official interaction profile is characterized by the lack of explicit, studied interactions rather than a list of known interacting substances. Patients should inform their doctor or pharmacist about all prescription and non-prescription products currently being used.

Advertisements

Mechanism of Action

The pharmacological function of Фуцидин Г is defined by a coordinated, dual-mechanism that targets the mechanisms of bacterial proliferation and host inflammation.

Targeted Inhibition of Bacterial Growth

This domain involves Fusidic Acid acting on bacterial molecular targets. Its mechanism is the targeted inhibition of the bacterial enzyme Elongation Factor G (EF-G), stabilizing it on the ribosome. This molecular arrest prevents the bacterium from synthesizing essential proteins, thereby immediately halting the proliferation of susceptible organisms (bacteriostasis).

Suppression of the Inflammatory Cascade

This domain is driven by Hydrocortisone activating the Cytosolic Glucocorticoid Receptor (GR) in host dermal cells. This binding modulates gene expression to suppress the release of pro-inflammatory mediators. The resulting cascade effectively limits the activity of Phospholipase A2, which is involved in the production of chemical signals such as Prostaglandins and Leukotrienes, contributing to the modulation of pathway activity within the tissue.

Pharmacodynamic Synergy

The concurrent action of the antibiotic (growth inhibition) and the corticosteroid (inflammation suppression) reflects complementary pharmacodynamic mechanisms. By simultaneously engaging mechanisms that inhibit microbial growth and those that suppress immunological signaling, the drug engages mechanisms that influence both the bacterial proliferation pathway and the host inflammatory pathway in the affected area.

Advertisements

Dosage and Administration Information

Official Administration Guidelines for Фуцидин Г (Fucidin H)

These instructions outline the proper use of Фуцидин Г (fusidic acid/hydrocortisone) as described in pharmaceutical documentation. This information is not intended as medical advice.

Administration Scope

Field Instruction
Route of Administration For cutaneous use only (topical application to the skin).
Dosing Schedule Apply a small quantity or a thin layer to the affected area.
Frequency Pattern Typically applied twice or three times daily.
Course Duration The treatment course should not normally exceed 14 days (2 weeks).

Procedural Steps

  1. Hand Hygiene: Wash hands thoroughly before and after applying the medication, unless the hands are the area being treated.
  2. Application: Gently rub a thin layer of the cream or ointment into the specific area of skin requiring treatment.
  3. Avoidance: Care must be taken to avoid getting the product into the eyes or on mucous membranes.
  4. Special Conditions: The use of occlusive dressings or bandaging is generally not recommended unless specifically directed by a healthcare professional, as this can increase systemic absorption.
  5. Missed Dose: If a dose is missed, apply it as soon as it is remembered. If it is almost time for the next scheduled dose, skip the missed one and continue with the regular schedule. Do not apply a double amount to make up for a missed dose.

Connection to the Official Use Protocol

The protocol for Фуцидин Г establishes a topical regimen defined by a limited daily frequency (twice or three times daily) and a maximum duration of 14 days. This procedural structure governs the product's application to ensure adherence to established application standards.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Фуцидин Г

This overview describes the clinical research that provides the evidence base for the combination medicine containing Fusidic Acid and Hydrocortisone. The information focuses on what studies have been conducted and what patterns the research highlights, without providing clinical advice or making claims about individual outcomes.


Evidence for Use in Infected Eczema and Dermatitis

Research for this medicine was studied for conditions characterized by fluctuating or episodic manifestations, specifically eczema and various forms of dermatitis where a secondary bacterial infection is present. The evidence base includes Randomized Controlled Trials (RCTs) and subsequent Systematic Reviews that analyze short-term findings.

In these studies, researchers monitored outcomes linked to inflammatory or irritative states and infection, such as pronounced redness (erythema), swelling, and itching (pruritus). The research also examined Bacteriological Outcomes, monitoring the presence or reduction of bacteria found at the site of infection. Standardized severity measures, such as the SCORAD scale, were applied in studies examining symptom intensity or variability.


How the Combination Was Studied Against Other Therapies

This medicine was evaluated in studies that compared the fixed combination against its individual components. Researchers often conducted RCTs that compared the dual treatment directly with the corticosteroid (Hydrocortisone) component alone. These studies explored the outcomes related to physical discomfort and clinical signs when comparing the fixed combination to using the steroid only.

In these research scenarios, the studies monitored outcomes reflecting daily functioning and overall clinical response. The combination was observed in comparative research exploring short-term symptom changes, allowing researchers to describe the relative response profiles.


Evidence Gaps and Areas of Uncertainty

As with many topical medications, evidence quality varies across studies, and the overall research base is subject to several limitations documented in the scientific literature. Follow-up durations were limited, contributing to the uncertainty regarding long-term outcomes for conditions where symptoms may vary in intensity.

Furthermore, comparative evidence is lacking for some relevant control arms, such as research comparing the combination to using the antibiotic component alone. The evidence is limited in defining a universally consistent clinical approach to classifying an infected skin condition, which is observed alongside some heterogeneity in the study populations. Findings describe group patterns, not personal outcomes; research highlights what is known — and what is still uncertain.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Фуцидин Г (FAQ)

Q: Can a person use Фуцидин Г for non-bacterial skin irritations?

Official product information states that this combination medicine is indicated for skin conditions like dermatitis where a secondary bacterial infection is suspected or confirmed. Due to the presence of the corticosteroid component, its use is specifically contraindicated in certain purely inflammatory conditions, such as rosacea and perioral dermatitis.

Q: Can Фуцидин Г cause skin thinning or color changes with use?

Yes, official regulatory documents note that potential effects related to the corticosteroid component include changes in the skin at the application site. Prolonged application may result in localized skin effects such as skin atrophy (thinning) or color changes known as depigmentation. Official product information notes that these effects are monitored in clinical settings.

Q: Are there any specific skincare products or cosmetics that should be avoided while using Фуцидин Г?

Regulatory information indicates that formal interaction studies between this topical medicine and other products have not been performed. No specific interactions with food, alcohol, or herbal products are documented in the official labeling. Official guidance recommends that a person informs their healthcare provider about all other topical products being used.

Q: What is the purpose of the 'Г' (G) component in the drug name?

The 'Г' component in the local name often corresponds to the Hydrocortisone active ingredient in the medication. This serves to differentiate this combination product (which contains both the antibiotic and the steroid) from formulations that contain only the antibiotic Fusidic Acid.

Q: What are the signs of an allergic reaction to Фуцидин Г that a person should look out for?

Signs of a serious allergic reaction, classified as rare in official documents, may include symptoms like swelling (especially of the face, tongue, or throat), severe rash, and difficulty breathing. The documentation indicates that these signs require immediate medical attention.

Q: Can individuals with a known allergy to other antibiotics use Фуцидин Г?

Official contraindications state that the product should not be used if there is a known hypersensitivity to fusidic acid, hydrocortisone, or any other components in the cream. Regulatory information generally does not detail the risk of cross-reactivity with other distinct classes of antibiotics.

Q: Is Фуцидин Г approved by major regulatory bodies like the FDA or EMA?

The official product information is published and regulated by major international bodies, including the European Medicines Agency (EMA) and the UK's MHRA. While the product's pharmacological classification is referenced in US regulatory databases, its primary documentation is maintained by these non-US agencies.

Q: What types of bacteria is the antibiotic component of Фуцидин Г primarily active against?

The antibiotic ingredient, fusidic acid, is described in official documents as being primarily active against susceptible microorganisms. This typically includes most strains of Staphylococcus aureus and also extends to certain Streptococci, Corynebacteria, Neisseria, and some Clostridia.

Q: Does applying too much Фуцидин Г increase the risk of side effects?

Official guidelines define the administration as applying a small quantity or thin layer. Applying the product to large surface areas or using it for prolonged periods increases the theoretical risk of rare systemic side effects, such as Adrenal Suppression.

Q: Can a person use another topical medication on the same area at a different time of day?

Formal interaction studies for co-administering topical products have not been performed according to official documents. To potentially minimize chemical or physical interaction, some patient guidance suggests spacing out the applications of different topical agents.

Q: What is the risk of the body becoming dependent on the steroid component?

Official warnings state that prolonged continuous topical administration is generally to be avoided. Due to the hydrocortisone content, extended use increases the risk of local skin effects like atrophy, as well as the theoretical risk of rare systemic effects.

Q: Does the time of day when Фуцидин Г is applied make a difference in its effectiveness?

Official instructions specify that the medicine is typically applied twice or three times daily. The product information emphasizes adhering to the required frequency and total course duration, rather than providing comparative efficacy data based on the time of day (such as morning versus evening) for application.

Q: How quickly should a person generally expect to see an improvement after starting Фуцидин Г?

Patient information indicates that a person should typically begin to notice their skin condition improve after just a few days of using the cream. Official guidance states that if no improvement is observed after seven days, the treatment is generally discontinued.

Q: Does sun exposure pose a risk while using Фуцидин Г?

Although the official product warnings do not list photosensitivity as a specific risk, general patient guidance suggests that the skin should be protected from excessive sun exposure while treating an inflamed skin condition. High sun exposure and heat may worsen certain types of skin inflammation.

Q: What should a person know about the risk of antibiotic resistance with this medication?

Regulatory documents include a warning that bacterial resistance has been reported with the use of fusidic acid. Using the medicine for extended periods or in recurrent courses may increase the likelihood of developing resistance to the antibiotic component.

Q: Are there special precautions for people with kidney or liver conditions using this drug?

Since the product is applied topically, systemic exposure is considered negligible. However, official warnings for the systemic (oral or intravenous) form of fusidic acid advise caution in patients with hepatic dysfunction (liver disease), as the drug is metabolized by the liver.

Q: What is the general recommendation for applying moisturizers while using Фуцидин Г?

Patient guidance suggests that if a person experiences irritation or dryness, applying an unscented moisturizer may be helpful. Patient guidance suggests that the moisturizer is generally applied after the medicinal cream to avoid interfering with the application of the active drug.

Q: What is the expected appearance or consistency of the cream or ointment?

The cream formulation of the product is officially described as a white, homogenous cream. This physical description is included to help ensure the product has been maintained correctly and is stable for use.

Q: Does the product contain any common allergens or preservatives?

Yes, official labeling lists the excipients (inactive ingredients) contained in the cream. These include butylhydroxyanisole (E320), cetyl alcohol, and potassium sorbate, which are ingredients that can potentially cause local skin reactions like contact dermatitis in sensitive individuals.

Advertisements

How should Фуцидин Г be stored and disposed of?

The official regulatory guidelines dictate specific conditions for storing and disposing of Фуцидин Г (Fucidin H Cream) to maintain its labeled stability and safety.

Storage and Container Rules

The medicine must be stored at a temperature that does not exceed 30 C. To prevent damage, the product must not be refrigerated or frozen. The cream should be kept in its original container with the cap tightly closed and must be stored out of the sight and reach of children.

Stability and Special Handling

The cream must not be used beyond the expiry date. Once the tube is initially opened, the product has a limited shelf life and must be discarded after 3 months (90 days). The label includes a fire hazard warning: materials that come into contact with the cream, such as clothing or bedding, can become flammable. Users are instructed not to smoke or go near naked flames during or immediately after use.

Disposal

To comply with environmental regulations, expired or unused medicine must not be thrown away with household waste or poured into wastewater. The correct disposal procedure is to return the product to a pharmacist.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Фуцидин Г found in:

A-Z Index: